{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T21:03:38Z","timestamp":1761512618854},"reference-count":25,"publisher":"BMJ","issue":"11","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Thorax"],"published-print":{"date-parts":[[1992,11,1]]},"DOI":"10.1136\/thx.47.11.932","type":"journal-article","created":{"date-parts":[[2008,12,13]],"date-time":"2008-12-13T03:22:59Z","timestamp":1229138579000},"page":"932-936","source":"Crossref","is-referenced-by-count":59,"title":["Intravenous pamidronate in the treatment of osteoporosis associated with corticosteroid dependent lung disease: an open pilot study."],"prefix":"10.1136","volume":"47","author":[{"given":"S J","family":"Gallacher","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J A","family":"Fenner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K","family":"Anderson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F M","family":"Bryden","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S W","family":"Banham","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F C","family":"Logue","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R A","family":"Cowan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"I T","family":"Boyle","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"239","reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1056\/NEJM198308043090502","article-title":"Steroid induced fractures and bone loss in patients with asthma","volume":"309","author":"Adinoff, A.D.; Hollister, JR","year":"1983","unstructured":"Adinoff AD, Hollister JR. Steroid induced fractures and bone loss in patients with asthma. N Engl i Med 1983;309:265-8.","journal-title":"N Engl i Med"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1172\/JCI108762","article-title":"Intestinal calcium absorption in exogenous hypercortisolism. Role of 25-hydroxyvitamin D and corticosteroid dose","volume":"60","author":"Klein, R.G.; Arnaud, S.B.; Gallagher, J.C.; DeLuca, H.F.; Riggs, B.L.","year":"1977","unstructured":"Klein RG, Arnaud SB, Gallagher JC, DeLuca HF, Riggs BL. Intestinal calcium absorption in exogenous hypercortisolism. Role of 25-hydroxyvitamin D and corticosteroid dose. J Clin Invest 1977;60:253-9.","journal-title":"J Clin Invest"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1210\/jcem-40-5-774","article-title":"Inhibition of leutinising hormone secretion induced by synthetic LRH by longterm treatment with glucocorticoids in human subjects","volume":"40","author":"Sakakura, M.; Takebe, K.; Nakagawa, S.","year":"1975","unstructured":"Sakakura M, Takebe K, Nakagawa S. Inhibition of leutinising hormone secretion induced by synthetic LRH by longterm treatment with glucocorticoids in human subjects. J Clin Endocrinol Metab 1975;40:774-9.","journal-title":"J Clin Endocrinol Metab"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/0026-0495(83)90221-4","article-title":"Importance of increased urinary calcium excretion in the development of secondary hyperparathyroidism of patients under glucocorticoid therapy","volume":"32","author":"Suzuki, Y.; Ichihawa, Y.; Saito, E.; Homma, M.","year":"1983","unstructured":"Suzuki Y, Ichihawa Y, Saito E, Homma M. Importance of increased urinary calcium excretion in the development of secondary hyperparathyroidism of patients under glucocorticoid therapy. Metabolism 1983;32:151-6.","journal-title":"Metabolism"},{"issue":"12","key":"ref_5","doi-asserted-by":"crossref","first-page":"352","DOI":"10.7326\/0003-4819-112-5-352","article-title":"Glucocorticoid-induced osteoporosis: Pathogenesis and management","volume":"1","author":"Lukert, B.P.; Raisz, L.G.","year":"1990","unstructured":"Lukert BP, Raisz LG. Glucocorticoid-induced osteoporosis: Pathogenesis and management. Ann Intern Med 1990;1 12:352-64.","journal-title":"Ann Intern Med"},{"key":"ref_6","first-page":"191","article-title":"Bone histomorphometry in corticosteroidinduced osteoporosis in Cushing's syndrome","volume":"171","author":"Meunier, P.J.; Dempster, D.W.; Edouard, C.; Chapuy, M.C.; Arlot, M.; Charlson, S.","year":"1984","unstructured":"Meunier PJ, Dempster DW, Edouard C, Chapuy MC, Arlot M, Charlson S. Bone histomorphometry in corticosteroidinduced osteoporosis in Cushing's syndrome. Adv Exp Med Biol 1984;171:191-200.","journal-title":"Adv Exp Med Biol"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1007\/BF02405069","article-title":"Mean wall thickness and formation periods of trabecular bone packets in corticosteroid-induced osteoporosis","volume":"35","author":"Dempster, D.W.; Arlot, M.A.; Meunier, P.J.","year":"1983","unstructured":"Dempster DW, Arlot MA, Meunier PJ. Mean wall thickness and formation periods of trabecular bone packets in corticosteroid-induced osteoporosis. Calcif Tissue Int 1983;35:410-7.","journal-title":"Calcif Tissue Int"},{"key":"ref_8","first-page":"1261","article-title":"Diphosphonates inhibit hydroxyapatite dissolution in vitro and bone resorption","volume-title":"tissue culture and in vivo. Science 1969","volume":"165","unstructured":"Fleisch H, Russell RGG, Francis MD. Diphosphonates inhibit hydroxyapatite dissolution in vitro and bone resorption in tissue culture and in vivo. Science 1969;165:1261-4."},{"key":"ref_9","first-page":"907","article-title":"Comparison of aminohydroxypropylidene diphosphonate, mithramycin, and corticosteroids\/calcitonin in treatment of cancerassociated hypercalcaemia","volume":"ii:","author":"Ralston, S.H.; Gardner, M.D.; Dryburgh, F.J.; Jenkins, A.S.; Cowan, R.A.; Boyle, I.T.","year":"1985","unstructured":"Ralston SH, Gardner MD, Dryburgh FJ, Jenkins AS, Cowan RA, Boyle IT. Comparison of aminohydroxypropylidene diphosphonate, mithramycin, and corticosteroids\/calcitonin in treatment of cancerassociated hypercalcaemia. Lancet 1985;ii:907-10.","journal-title":"Lancet"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1016\/S0140-6736(71)91447-4","article-title":"Diphosphonates and Paget's disease of bone","volume":"i:","author":"Smith, R.; Russell, R.G.G.; Bishop, M.","year":"1971","unstructured":"Smith R, Russell RGG, Bishop M. Diphosphonates and Paget's disease of bone. Lancet 1971;i:945-7.","journal-title":"Lancet"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1056\/NEJM199005033221803","article-title":"Effect of intermittent cyclical etidronate therapy on bone mass and fracture rate in women with postmenopausal osteopoxosis","volume":"322","author":"Storm, T.; Thamsborg, G.; Steiniche, T.; Genant, H.K.; Sorensen, O.H.","year":"1990","unstructured":"Storm T, Thamsborg G, Steiniche T, Genant HK, Sorensen OH. Effect of intermittent cyclical etidronate therapy on bone mass and fracture rate in women with postmenopausal osteopoxosis. N Engi J Med 1990;322:1265-71.","journal-title":"N Engi J Med"},{"key":"ref_12","first-page":"3","article-title":"Intermittentcyclical etidronate treatmelgf postmenopausal osteoporosis","author":"Watts, N.B.; Harris, S.T.; Genant, H.K.; Wasnich, R.D.; Miller, P.D.; Jackson, R.D.","year":"1990","unstructured":"Watts NB, Harris ST, Genant HK, Wasnich RD, Miller PD, Jackson RD, et al. Intermittentcyclical etidronate treatmelgf postmenopausal osteoporosis. N Engi J Med 1990;3nZ.73-9.","journal-title":"N Engi J Med"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/0221-8747(81)90041-2","article-title":"Biochemical markers of bone turnover 4\"","volume":"3","author":"Russell, R.G.G.; Beard, D.G.; Cameron, E.C.; Douglas, D.L.; Forrest, A.R.W.; Guilland-Cuinmning, D.","year":"1981","unstructured":"Russell RGG, Beard DG, Cameron EC, Douglas DL, Forrest ARW, Guilland-Cuinmning D, et al. Biochemical markers of bone turnover 4\" Paget's disease. Metabolic Bone Disease and Related Reiearch 1981;3:255-62.","journal-title":"Paget's disease. Metabolic Bone Disease and Related Reiearch"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1530\/acta.0.1060556","article-title":"Circulating vitamin D metabolites and hypercalcaemia of malignancy","volume":"106","author":"Ralston, S.H.; Cowan, R.A.; Robertson, A.G.; Gardner, M.D.; Boyle, I.T.","year":"1984","unstructured":"Ralston SH, Cowan RA, Robertson AG, Gardner MD, Boyle IT. Circulating vitamin D metabolites and hypercalcaemia of malignancy. Acta Endicrinol 1984;106: 556-63.","journal-title":"Acta Endicrinol"},{"key":"ref_15","first-page":"42","article-title":"Side effects of pamidronate","volume":"ii:","author":"Gallacher, S.J.; Ralston, S.H.; Patel, U.; Boyle, I.T.","year":"1989","unstructured":"Gallacher SJ, Ralston SH, Patel U, Boyle IT. Side effects of pamidronate. Lancet 1989;ii:42-3.","journal-title":"Lancet"},{"key":"ref_16","first-page":"213","article-title":"Glucocorticoids and bone","volume-title":"Mineral Research\/3","author":"Gennari, C.","unstructured":"Gennari C. Glucocorticoids and bone. In: Peck WA, ed. Bone and Mineral Research\/3. Amsterdam: Elsevier 1985:213-32."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1136\/ard.50.12.930","article-title":"Clinical experience with pamidronate in Paget's disease of bone","volume":"50","author":"Gallacher, S.J.; Boyce, B.F.; Patel, U.; Jenkins, A.; Ralston, S.H.; Boyle, I.T.","year":"1991","unstructured":"Gallacher SJ, Boyce BF, Patel U, Jenkins A, Ralston SH, Boyle IT. Clinical experience with pamidronate in Paget's disease of bone. Ann Rheum Dis 1991;50:930-3.","journal-title":"Ann Rheum Dis"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/0169-6009(91)90130-R","article-title":"A comparison of low versus high dose pamidronate in cancer-associated hypercalcaemia","volume":"15","author":"Gallacher, S.J.; Ralston, S.H.; Fraser, W.D.; Dryburgh, F.J.; Cowan, R.A.; Logue, F.C.; Boyle, I.T.","year":"1991","unstructured":"Gallacher SJ, Ralston SH, Fraser WD, Dryburgh FJ, Cowan RA, Logue FC, Boyle IT. A comparison of low versus high dose pamidronate in cancer-associated hypercalcaemia. Bone Mineral 1991;15:249-56.","journal-title":"Bone Mineral"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1111\/j.1365-2265.1986.tb03254.x","article-title":"Absorption of oral diphosphonates in normal subjects","volume":"24","author":"Fogelman, I.; Smith, L.; Mazess, R.; Wilson, M.A.; Bevan, J.A.","year":"1986","unstructured":"Fogelman I, Smith L, Mazess R, Wilson MA, Bevan JA. Absorption of oral diphosphonates in normal subjects. Clin Endocrinol 1986;24:57-62.","journal-title":"Clin Endocrinol"},{"key":"ref_20","first-page":"821","article-title":"Focal osteomalacia due to low dose diphosphonate therapy in Paget's disease","volume":"1","author":"Boyce, B.F.; Smith, L.; Fogelman, I.; Johnston, E.; Ralston, S.; Boyle, I.T.","year":"1984","unstructured":"Boyce BF, Smith L, Fogelman I, Johnston E, Ralston S, Boyle IT. Focal osteomalacia due to low dose diphosphonate therapy in Paget's disease. Lancet 1984;1:821-4.","journal-title":"Lancet"},{"key":"ref_21","first-page":"143","article-title":"Prevention of steroid-induced osteoporosis with","volume":"i:","author":"Reid, I.R.; King, A.R.; Alexander, C.J.; Ibbertson, H.K.","year":"1988","unstructured":"Reid IR, King AR, Alexander CJ, Ibbertson HK. Prevention of steroid-induced osteoporosis with (3-amino-ihydroxypropylidene)-1, 1 -bisphosphonate (APD). Lancet 1988;i: 143-6.","journal-title":"Lancet"},{"issue":"144","key":"ref_22","article-title":"Two year follow up of bisphosphonate (APD) treatment in steroid osteoporosis Lancet","volume":"1","author":"Reid, I.R.; Heap, S.W.; King, A.R.; Ibbertson, H.K.","year":"1988","unstructured":"Reid IR, Heap SW, King AR, Ibbertson, HK. Two year follow up of bisphosphonate (APD) treatment in steroid osteoporosis Lancet 1988;ii: 1 144."},{"key":"ref_23","first-page":"273","article-title":"Morphologic basis of bone mineral measurements: transient and steady state effects of treatment in osteoporosis","volume":"4","author":"Parfitt, A.M.","year":"1980","unstructured":"Parfitt AM. Morphologic basis of bone mineral measurements: transient and steady state effects of treatment in osteoporosis. Miner Electrolyte Metab 1980;4:273-87.","journal-title":"Miner Electrolyte Metab"},{"key":"ref_24","first-page":"123","article-title":"Reduction of serum 1, 25 dihydroxyvitamin D3 in children receiving glucocorticoids","volume":"1","author":"Chesney, R.W.; Mazess, R.B.; Hamstra, A.J.; DeLuca, H.F.; O'Reagan, S.","year":"1978","unstructured":"Chesney RW, Mazess RB, Hamstra AJ, DeLuca HF, O'Reagan S. Reduction of serum 1, 25 dihydroxyvitamin D3 in children receiving glucocorticoids. Lancet 1978;ii:1 123-5.","journal-title":"Lancet"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1210\/jcem-52-1-111","article-title":"Effects of short term glucocorticoid administration on intestinal calcium absorption and circulating vitamin D metabolite concentration in man","volume":"52","author":"Hahn, T.J.; Halstead, L.R.; Baran, T.J.","year":"1981","unstructured":"Hahn TJ, Halstead LR, Baran TJ. Effects of short term glucocorticoid administration on intestinal calcium absorption and circulating vitamin D metabolite concentration in man. J Clin Endocrinol Metab 1981;52:111-5.","journal-title":"J Clin Endocrinol Metab"}],"container-title":["Thorax"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/thx.47.11.932","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,9,26]],"date-time":"2020-09-26T09:13:31Z","timestamp":1601111611000},"score":1,"resource":{"primary":{"URL":"https:\/\/thorax.bmj.com\/lookup\/doi\/10.1136\/thx.47.11.932"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1992,11,1]]},"references-count":25,"journal-issue":{"issue":"11","published-print":{"date-parts":[[1992,11,1]]}},"URL":"https:\/\/doi.org\/10.1136\/thx.47.11.932","relation":{},"ISSN":["0040-6376"],"issn-type":[{"value":"0040-6376","type":"print"}],"subject":[],"published":{"date-parts":[[1992,11,1]]}}}